Nasdaq Vrax News Today

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 12,000 shares, a growth of 300.0% from the March 31st total of 3,000 shares. Based on an average daily trading volume, of 73,000 shares, the […]

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 100,500 shares, an increase of 233.9% from the January 15th total of 30,100 shares. Based on an average daily volume of 124,700 […]

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 30,100 shares, a decrease of 78.3% from the December 31st total of 138,600 shares. Approximately 2.6% of the company’s stock are short sold. Based on […]

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 72,100 shares, a decrease of 24.7% from the October 15th total of 95,700 shares. Based on an average daily trading volume, of 167,400 shares, the […]

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 24,900 shares, a drop of 48.2% from the July 15th total of 48,100 shares. Approximately 0.3% of the company’s shares are short […]

Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Lucira Health (NASDAQ:LHDX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Analyst Recommendations This is a summary of current […]

Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Achieve Life Sciences (NASDAQ:ACHV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends. Valuation and Earnings This table compares Virax […]

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Rating)’s stock price traded down 1.9% during trading on Wednesday . The stock traded as low as $0.35 and last traded at $0.35. 65,475 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 1,317,966 shares. The stock had previously closed at […]

Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Valuation & Earnings This table compares Virax Biolabs […]

Let’s start up with the current stock price of Virax Biolabs Group Limited (VRAX), which is $2.81 to be very precise. The Stock rose vividly during the last session to $3.17 after opening rate of $3.08 while the lowest price it went was recorded $2.71 before closing at $3.28.Recently in News on Se